(Q56804215)

English

Spirapril

No description defined

In more languages

Statements

scholarly article

0 references

Spirapril (English)

0 references

author name string

Stuart Noble

1

0 references

Eugene M. Sorkin

2

0 references

publication date

May 1995

0 references

0 references

49

0 references

5

0 references

750-766

0 references

https://scigraph.springernature.com/pub.10.2165/00003495-199549050-00008

0 references

Placebo-controlled crossover comparison of spirapril at 3, 6, 12 and 24 mg once daily in mild to severe essential hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/7601014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cough and ACE inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/7601014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Concomitant administration of isradipine and spirapril prevents reduction of renal function induced by acute administration of spirapril in patients with reduced renal function

1 reference

https://pubmed.ncbi.nlm.nih.gov/7601014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Spirapril in chronic renal failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/7601014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Short- and long-term effects of spirapril on renal hemodynamics in patients with essential hypertension.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7601014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacologic, metabolic, and toxicologic profile of spirapril (SCH 33844), a new angiotensin converting inhibitor.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7601014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of antihypertensive medication on hypertension in patients with sleep apnoea.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7601014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changes in left ventricular dimensions and haemodynamics during antihypertensive treatment with spirapril for 36 months

1 reference

https://pubmed.ncbi.nlm.nih.gov/7601014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of spirapril and spiraprilat in patients with chronic renal failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/7601014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Acute Hemodynamic, Hormonal, and Pharmacokinetic Properties of Oral Spirapril in Patients with Moderate to Severe Heart Failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/7601014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Single daily administration of spirapril in the treatment of essential hypertension. A multicentre double-blind comparison of 1, 6, 12 and 24 mg of spirapril once daily

1 reference

https://pubmed.ncbi.nlm.nih.gov/7601014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and haemodynamic effects of a single oral dose of the novel ACE inhibitor spirapril in patients with chronic liver disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/7601014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiotensin converting enzyme inhibitors and moderate hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/7601014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Placebo-controlled comparison of spirapril at 6, 12 and 24 mg/day in mild to severe essential hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/7601014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiotensin converting enzyme inhibitory activity of SCH 33844 (spirapril) in rats, dogs and monkeys

1 reference

https://pubmed.ncbi.nlm.nih.gov/7601014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of spirapril and isradipine in patients with diabetic nephropathy and hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/7601014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The positive association of cough with angiotensin-converting enzyme inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/7601014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

24-hour ambulatory blood pressure monitoring and spirapril in mild to severe essential hypertension: a randomized dose comparison

1 reference

https://pubmed.ncbi.nlm.nih.gov/7601014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Are the renal haemodynamic and natriuretic effects of calcium antagonists and angiotensin converting inhibitors additive?

1 reference

https://pubmed.ncbi.nlm.nih.gov/7601014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quinapril. A review of its pharmacological properties, and therapeutic efficacy in cardiovascular disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/7601014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Discrepancy between renin mRNA and plasma renin level in angiotensin-converting enzyme inhibitor-treated rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/7601014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Partial escape of angiotensin converting enzyme (ACE) inhibition during prolonged ACE inhibitor treatment: does it exist and does it affect the antihypertensive response?

1 reference

https://pubmed.ncbi.nlm.nih.gov/7601014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of spirapril in renal impairment

1 reference

https://pubmed.ncbi.nlm.nih.gov/7601014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical use of angiotensin-converting enzyme inhibitors in patients with renal impairment.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7601014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiotensin converting enzyme inhibitors versus digoxin for the treatment of congestive heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/7601014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sustained-release isradipine compared with spirapril in the treatment of elderly patients with isolated systolic hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/7601014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fosinopril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in essential hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/7601014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A multicentre multidose study of the efficacy and safety of spirapril in mild-to-moderate essential hypertension. UK Study Group of Spirapril in Hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/7601014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Perindopril. A review of its pharmacological properties and therapeutic use in cardiovascular disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/7601014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathogenetic role of vascular angiotensin-converting enzyme in the spontaneously hypertensive rat.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7601014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of ACE inhibition on autonomic vascular control, as assessed by spectral analysis, and on haemodynamics

1 reference

https://pubmed.ncbi.nlm.nih.gov/7601014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Spirapril: pharmacokinetic properties and drug interactions

1 reference

https://pubmed.ncbi.nlm.nih.gov/7601014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of long-term treatment with an angiotensin-converting enzyme inhibitor on the renin-angiotensin system in spontaneously hypertensive rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/7601014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regression of left ventricular hypertrophy by spirapril

1 reference

https://pubmed.ncbi.nlm.nih.gov/7601014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Benazepril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and congestive heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/7601014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Digoxin pharmacokinetics and spirapril, a new ace inhibitor

1 reference

https://pubmed.ncbi.nlm.nih.gov/7601014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiotensin-converting enzyme inhibitors and cough. Prevalence in an outpatient medical clinic population

1 reference

https://pubmed.ncbi.nlm.nih.gov/7601014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00003495-199549050-00008

0 references

Dimensions Publication ID

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q56804215&oldid=1506438589"